Cargando…
Efficacy and safety of ShenSongYangXin Capsule combined with antiarrhythmic drugs for atrial fibrillation: A protocol for systematic review and network meta-analysis
BACKGROUND: Shen-Song-Yang-Xin Capsule (SSYX), a Chinese patent medicine, combined with antiarrhythmic drugs (AADs) in the treatment of atrial fibrillation (AF) has been widely applied in clinical practice, but the results are controversial. This study aims to conduct a network meta-analysis (NMA) b...
Autores principales: | Shi, Shuqing, Shi, Jingjing, Jia, Qiulei, Shi, Shuai, Yuan, Guozhen, Hu, Yuanhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545279/ https://www.ncbi.nlm.nih.gov/pubmed/32957412 http://dx.doi.org/10.1097/MD.0000000000022367 |
Ejemplares similares
-
Effect of Shen Song Yang Xin Capsule on Myocardial Electrophysiology of Acute Atrial Fibrillation in Canine Model
por: Zhang, Kai, et al.
Publicado: (2017) -
Comparative efficacy and safety of wenxin granule combined with antiarrhythmic drugs for atrial fibrillation: A protocol for a systematic review and network meta-analysis
por: Shi, Shuqing, et al.
Publicado: (2021) -
The efficacy and safety of amiodarone combined with beta-blockers in the maintenance of sinus rhythm for atrial fibrillation: A protocol for systematic review and network meta-analysis
por: Shi, Shuqing, et al.
Publicado: (2020) -
Global research productions pertaining to atrial fibrillation from 2004 to 2018: A bibliometric analysis
por: Shi, Shuqing, et al.
Publicado: (2020) -
Identification of Proteins Implicated in the Increased Heart Rate in ShenSongYangXin-Treated Bradycardia Rabbits by iTRAQ-Based Quantitative Proteomics
por: Liu, Zhouying, et al.
Publicado: (2015)